Sharechat Logo

The a2 Milk Company Limited (NZX: ATM) to Defend Second Class Action

Wednesday 24th November 2021

Text too small?

On 6 October 2021, The a2 Milk Company Limited (“the Company”) announced it had been notified that group proceedings had been filed in the Supreme Court of Victoria by Slater & Gordon Lawyers, which named the Company as the defendant.

On 21 October 2021, the Company announced that it was aware of reports in the media that a potential class action against the Company was being investigated by Shine Lawyers.

Today the Company was served with a representative proceeding filed in the Supreme Court of Victoria by Shine Lawyers, which names the Company as the defendant. The proceeding relates to the period from 19 August 2020 to 9 May 2021 and makes allegations which are broadly similar to those advanced by the class action proceeding filed by Slater and Gordon Lawyers on 6 October 2021.

The Company considers that it has at all times complied with its disclosure obligations, denies any liability and will vigorously defend the proceedings.

Please see the link below for details

The a2 Milk Company to defend second class action

Source: The a2 Milk Company Limited

  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

Meridian Energy monthly operating report for July 2022
Cannasouth to launch a pro-rata renounceable rights issue
August 12th Morning Report
2022 Annual Shareholders' Meeting & Director Nominations
Rakon 2022 Annual Meeting Chair's Address and Presentation
VHP - Full year results release
RAKON FY23 Earnings Guidance
August 11th Morning Report
Deferral of FDA consideration of enforcement discretion
MHJ - Response to ASX Query